EULAV Asset Management’s Elevance Health ELV Stock Holding History

EULAV Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-7,000	Closed	-$919K	–	278
2016 Q2	$919K	Hold	7,000	–	–	0.05%	243
2016 Q1	$973K	Hold	7,000	–	–	0.05%	245
2015 Q4	$976K	Hold	7,000	–	–	0.05%	255
2015 Q3	$980K	Hold	7,000	–	–	0.06%	262
2015 Q2	$1.15M	Hold	7,000	–	–	0.06%	271
2015 Q1	$1.08M	Buy	+7,000	New	+$997K	0.06%	283
2014 Q4	–	Sell	-7,000	Closed	-$837K	–	339
2014 Q3	$837K	Hold	7,000	–	–	0.05%	304
2014 Q2	$753K	Hold	7,000	–	–	0.04%	334
2014 Q1	$697K	Hold	7,000	–	–	0.04%	339
2013 Q4	$647K	Hold	7,000	–	–	0.04%	350
2013 Q3	$585K	Hold	7,000	–	–	0.03%	364
2013 Q2	$573K	Buy	+7,000	New	+$524K	0.03%	364

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

EULAV Asset Management's ELV Position: Q3 2016 in Review

EULAV Asset Management sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 7,000 shares — an estimated $919K sold.

EULAV Asset Management first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $1.15M in Q2 2015. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

EULAV Asset Management reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
EULAV Asset Management sold 7,000 Elevance Health shares in Q3 2016, an estimated $919K.
EULAV Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
EULAV Asset Management's Elevance Health position peaked at $1.15M in Q2 2015.
737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on EULAV Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.